Oral treatment with SEW2871, a sphingosine‐1‐phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin‐10 gene deficient mice
作者： J. Dong , H. Wang , G. Wu , J. Zhao , L. Zhang
DOI: 10.1111/CEI.12304
关键词: Immunology 、 Receptor 、 Serum amyloid A 、 Colitis 、 Proinflammatory cytokine 、 Interleukin 10 、 Inflammation 、 Medicine 、 Interleukin 、 Myeloperoxidase
摘要: … SEW2871 on colitis remain unclear. The aim of this study was to investigate the effects of SEW2871 … SEW2871 was administered by gavage at a dose of 20 mg/kg/day for 2 weeks to IL-…
oup.com
sci-hub.se 参考文章(42)
Udai P Singh, Shailesh Singh, Dennis D Taub, James W Lillard, None, Inhibition of IFN-γ-Inducible Protein-10 Abrogates Colitis in IL-10−/− Mice Journal of Immunology. ,vol. 171, pp. 1401- 1406 ,(2003) , 10.4049/JIMMUNOL.171.3.1401
Carolin Daniel, Nico Sartory, Nadine Zahn, Gerd Geisslinger, Heinfried H. Radeke, Juergen M. Stein, FTY720 ameliorates th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells Journal of Immunology. ,vol. 178, pp. 2458- 2468 ,(2007) , 10.4049/JIMMUNOL.178.4.2458
Yi Li, Colin de Haar, Maikel P. Peppelenbosch, Janneke C. van der Woude, New insights into the role of STAT3 in IBD. Inflammatory Bowel Diseases. ,vol. 18, pp. 1177- 1183 ,(2012) , 10.1002/IBD.21884
Juan Rivera, Richard L. Proia, Ana Olivera, The alliance of sphingosine-1-phosphate and its receptors in immunity Nature Reviews Immunology. ,vol. 8, pp. 753- 763 ,(2008) , 10.1038/NRI2400
AiPing Bai, PinJin Hu, Jie Chen, Xin Song, Wei Chen, WenXin Peng, ZhiRong Zeng, Xiang Gao, Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis International Journal of Colorectal Disease. ,vol. 22, pp. 625- 635 ,(2007) , 10.1007/S00384-006-0229-Z
Lai Wei, Arian Laurence, Kevin M. Elias, John J. O'Shea, IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. Journal of Biological Chemistry. ,vol. 282, pp. 34605- 34610 ,(2007) , 10.1074/JBC.M705100200
Yasuaki Sanada, Tsunekazu Mizushima, Yasuyuki Kai, Junichi Nishimura, Hiroshi Hagiya, Haruto Kurata, Hirotaka Mizuno, Etsuko Uejima, Toshinori Ito, Therapeutic Effects of Novel Sphingosine-1-Phosphate Receptor Agonist W-061 in Murine DSS Colitis PLoS ONE. ,vol. 6, pp. e23933- ,(2011) , 10.1371/JOURNAL.PONE.0023933
Matthew A. Burchill, Jianying Yang, Kieng B. Vang, Michael A. Farrar, Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunology Letters. ,vol. 114, pp. 1- 8 ,(2007) , 10.1016/J.IMLET.2007.08.005
S. Brand, Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease Gut. ,vol. 58, pp. 1152- 1167 ,(2009) , 10.1136/GUT.2008.163667
Yasuyuki Deguchi, Akira Andoh, Yuki Yagi, Shigeki Bamba, Osamu Inatomi, Tomoyuki Tsujikawa, Yoshihide Fujiyama, The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice. Oncology Reports. ,vol. 16, pp. 699- 703 ,(2006) , 10.3892/OR.16.4.699